A Preliminary Study on the Establishment of the PDTX Model

Area of Science:

• Oncology
• Translational Research
• Cancer Modeling

Background:

• Gastric cancer remains a significant global health challenge.
• Accurate preclinical models are crucial for advancing cancer therapy.
• Patient-derived tumor xenograft (PDTX) models offer a promising avenue for personalized medicine.

Purpose of the Study:

• To investigate the feasibility and success rate of establishing patient-derived tumor xenograft (PDTX) models for gastric cancer.
• To assess the fidelity of PDTX models in recapitulating the characteristics of primary human tumors.

Main Methods:

• Twenty gastric cancer patients (10 male, 10 female) were enrolled.
• Xenografts were monitored for volume, invasion, and metastasis.
• Pathological evaluation using H&E staining and immunohistochemistry compared PDTX and primary tumor tissues.

Main Results:

• Successful establishment of PDTX models in 15 out of 20 patients, achieving a 75% success rate.
• PDTX models accurately maintained the differentiation, morphology, and structural characteristics of the original tumor cells.
• Demonstrated high correlation between xenograft and patient primary tumor tissues.

Conclusions:

• The PDTX model serves as a viable substitute for patients in preclinical settings.
• This model is suitable for clinical pharmacodynamic screening.
• PDTX models hold significant potential for novel anti-cancer drug development and personalized treatment strategies.